High-Sensitivity Analysis of Drugs in Ultra-Small Volume Plasma Samples Using Microflow LC/MS/MS

Importance of the Topic

Drug metabolism studies rely on sensitive detection of parent compounds and metabolites in biological samples. Conventional LC-MS/MS methods often require large sample volumes, raising ethical and cost concerns in preclinical pharmacokinetic research. Microflow LC-MS/MS addresses these challenges by enhancing sensitivity while reducing plasma volume requirements, enabling efficient drug quantitation in ultra-small samples.

Objectives and Study Overview

This study aimed to develop a high-sensitivity microflow LC-MS/MS method for quantifying Verapamil and its metabolite Nor-Verapamil in ultra-small (2 µL) rat plasma samples. The method performance was benchmarked against a conventional semi-microflow approach to demonstrate sensitivity gains and robustness.

Methodology and Instrumentation

The trap-and-elute workflow was implemented on a Shimadzu Nexera Mikros system, capable of flows from 1 to 500 µL/min. Plasma samples spiked with analytes and Verapamil-D6 internal standard were deproteinized with acetonitrile/formic acid, incubated, centrifuged, and 5 µL of supernatant injected.

Used Instrumentation

• Shimadzu Nexera Mikros microflow LC-MS system
• Shim-pack MC PLONAS Biphenyl analytical column (2.7 µm, 100 mm × 0.2 mm)
• Shim-pack MCT LC8 trap column (5 µm, 5 mm × 0.3 mm)
• Micro-ESI probe, LCMS-8060 mass spectrometer

Main Results and Discussion

Compared to semi-microflow analysis (100–500 µL/min), the microflow method (4 µL/min elution) achieved a 4.5-fold increase in Verapamil signal and 3.5-fold increase for Nor-Verapamil. Calibration curves over 0.5–181.6 µg/L showed excellent linearity (R2 > 0.998) and accuracy within 90–110% for both compounds. Trap-and-elute injection overcame peak broadening caused by acetonitrile in the sample matrix, maintaining narrow peaks and consistent retention.

Benefits and Practical Applications

• Enhanced sensitivity allows reliable quantitation at low concentration levels in minimal plasma volume.
• Reduced animal usage and sample consumption support ethical and cost-effective preclinical studies.
• Robust microflow operation yields shorter analysis times and improved method stability versus nano-LC.

Future Trends and Applications

The integration of microflow LC-MS/MS with advanced micro-sampling techniques and automation is expected to further decrease sample requirements and increase throughput. Emerging developments in ionization technology and high-resolution mass spectrometry may expand applications to diverse biological matrices and multiplexed assays.

Conclusion

The trap-and-elute microflow LC-MS/MS method on the Shimadzu Nexera Mikros platform demonstrated significant sensitivity improvements for Verapamil and Nor-Verapamil analysis in ultra-small plasma samples. This approach supports efficient, ethical, and reliable preclinical pharmacokinetic investigations.

References

1 Rapid Communications in Mass Spectrometry, 2014, 28, 1293–1302.